Medical Device Patient Safety Act Proposes Two-Step Change to Oversight of Devices


In mid-December of 2011, following the recommendation of the Government Accountability Office (GAO), a bipartisan group of senators introduced the Medical Device Patient Safety Act.  According to the GAO, the Food and Drug Administration's (FDA) lack of oversight of medical devices once they are on the market has created a high-risk situation for consumers.

Under the existing framework, the FDA has limited ability to monitor medical devices once they are cleared under the 510(k) process.  As a result, according to the GAO, faulty products are not identified quickly enough.  The Act proposes a two-step change in order to meet two goals, as identified by Sen. Chuck Grassley (R-Iowa): (1) to improve the recall process and (2) to enhance post-market surveillance tools.

The Act's first change would require the FDA to track and trend medical device recall data.  Currently, the FDA has the authority to track recall data, but is not required to do so.  Under the Act, a program to routinely and systematically assess "(1) information submitted during a device recall and (2) information regarding a correction or removal of a device" would be created. Additionally, the FDA would be required to "(1) assess information submitted to proactively identify strategies for mitigating health risks presented by defective or unsafe devices and (2) develop explicit criteria of assessing whether the recall was done effectively."  This charge appears to give the FDA tremendous freedom in determining what constitutes an effective recall.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Sedgwick LLP | Attorney Advertising

Written by:


Sedgwick LLP on:

Popular Topics
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.